YOU ARE HERE: HOME > news & events > events

JSCPT 2025

Event Date:
5th –6th December 2025
Location:
Tokyo, Japan

Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.

View Event

AHA Scientific Sessions 2025

Event Date:
8th–10th November 2025
Location:
New Orleans, USA

Richmond Pharmacology will attend AHA Scientific Sessions 2025 in New Orleans, with CEO Dr Jörg Täubel and CSO James Rickard. They will discuss early-phase cardiovascular research, digital endpoints, regulatory engagement, and patient-first strategies.

View Event

AASLD Liver Meeting 2025

Event Date:
7th -11th November 2025
Location:
Washington, DC, USA

Richmond Pharmacology will attend The Liver Meeting 2025 in Washington, DC, represented by James Rickard. Key topics include early-phase hepatology trials, non-invasive biomarkers, regulatory strategy, and patient-focused approaches in liver studies.

View Event

BioJapan 2025

Event Date:
8th –10th October 2025
Location:
Yokohama, Japan

Richmond Pharmacology will attend BioJapan 2025 in Yokohama, represented by their leadership team. The event focuses on early-phase trials, UK–Japan collaboration, regulatory strategy, bridging studies, and adaptive trial models.

View Event

BioJapan 2025

Event Date:
8th –10th October 2025
Location:
Yokohama, Japan

Richmond Pharmacology will attend BioJapan 2025 in Yokohama, represented by their leadership team. The event focuses on early-phase trials, UK–Japan collaboration, regulatory strategy, bridging studies, and adaptive trial models.

View Event

ACCP Annual Meeting 2025

Event Date:
14th –16th September 2025
Location:
Phoenix, AZ, USA

Richmond Pharmacology will be present at the ACCP Annual Meeting 2025 in Phoenix, Arizona, with CEO Dr Jörg Täubel and CSO James Rickard. Topics include translational clinical pharmacology, innovative trial design, PK/PD modelling, and regulatory collaboration.

View Event

AHA Hypertension Scientific Sessions 2025

Event Date:
4th –7th September 2025
Location:
Baltimore, MD, USA

Richmond Pharmacology will attend AHA Hypertension Scientific Sessions 2025 in Baltimore, represented by CEO Dr Jörg Täubel and CSO James Rickard. Discussions will include early-phase hypertension research, BP monitoring, regulatory strategy, and patient-centric design.

View Event

ESC Congress 2025

Event Date:
29th August – 1st September 2025
Location:
Madrid, Spain

Richmond Pharmacology will attend ESC Congress 2025 in Madrid, represented by CEO Dr Jörg Täubel. The team will discuss early-phase cardiovascular and cardiometabolic trials, novel endpoints, risk-stratified study design, accelerated drug development, and patient-focused recruitment.

View Event

BIO International Convention 2025

Event Date:
16-19 June 2025
Location:
Boston, US

Richmond Pharmacology will be attending the BIO International Convention 2025 in Boston, connecting with biotech innovators at Booth 765.

View Event

HFA 2025

Event Date:
17–20 May 2025
Location:
Belgrade, Serbia

Richmond Pharmacology will participate in HFA 2025 in Belgrade from 17–20 May, focusing on heart failure research, clinical trials, and scientific collaboration.

View Event

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Events

BioJapan 2025

8th –10th October 2025
Richmond Pharmacology will attend BioJapan 2025 in Yokohama, represented by their leadership team. The event focuses on early-phase trials, UK–Japan collaboration, regulatory strategy, bridging studies, and adaptive trial models.
View event
© 2024 Richmond Pharmacology - all rights reserved
Disclaimer
|
Sitemap
|
Privacy Policy
|
Report A Concern
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesRejectAccept